Be The First To
ImmunoGen is TAP, TAP, TAPping its way toward a cure for cancer. The firm's product candidates are TAPs, or tumor-activated prodrugs, that combine cancer-killing drugs with monoclonal antibodies (single-source proteins) and attach only to tumor cells. Its lead compounds are trastuzumab emtansine, which is being developed with Genentech to treat breast cancer; lorvotuzumab mertansine to treat solid tumors and multiple myelomas; and SAR3419 for non-Hodgkin's lymphoma. Along with good ol' R&D, a large part of ImmunoGen's business is derived from licensing its TAP technology...
This is the employer's chance to tell you why you should work for them. The information provided is from their perspective.
Employees are “Satisfied” 6 ratings
75% of the CEO 5 ratings
President, CEO, and Director
|Salaries in USD||Avg. Salary|| |
5 ImmunoGen Salaries
4 ImmunoGen Salaries
3 ImmunoGen Salaries
= Salary Range
= Anonymous Salary Range
Accepted Offer – Interviewed in Waltham, MA – Reviewed Jul 3, 2014
Interview Details – The process was quite easy. The interviews were all done in one day, however, there were many people with which I had to meet. Long day, but overall good experience. – Full Interview
There weren't any really hard questions asked. Mostly were simply "Do you know how to..." or "What would you do if..." questions. – Answer Question
Let us know if we're missing any workplace or industry recognition –